eli lilly benelux
Eli Lilly Benelux is the Belgian subsidiary of Eli Lilly and Company, marketing and distributing prescription pharmaceutical medicines across diabetes, oncology, immunology, pain, and neurodegeneration to patients and healthcare professionals in Belgium through regulated pharmacy and healthcare channels.
- Company typePublic
- Founded1876
- HeadquartersBrussels, Belgium
- Headcount—
- GTM typeB2B
- OfferingHardware or Manufacturing
eli lilly benelux firmographics
Firmographics- Name
- eli lilly benelux
- Legal name
- Eli Lilly and Company
- Website
- https://lilly.be
- Company type
- Public
- Founded year
- 1876
- Operating status
- Operating
- Short description
- Eli Lilly Benelux is the Belgian subsidiary of Eli Lilly and Company, marketing and distributing prescription pharmaceutical medicines across diabetes, oncology, immunology, pain, and neurodegeneration to patients and healthcare professionals in Belgium through regulated pharmacy and healthcare channels.
- Ownership category
- akta.pro rank
eli lilly benelux industry classification
Industry- Product category
- Pharmaceuticals
- NAICS
- Pharmaceutical Preparation Manufacturing (325412), Pharmaceutical and Medicine Manufacturing (32541)
- SIC
- Pharmaceutical Preparations (2834)
- akta.pro industry
- Primary Care & General Medicine PharmaceuticalsCardiometabolic Pharmaceuticals (Cardiovascular/Diabetes/Obesity)Endocrinology & Reproductive Health Pharmaceuticals (incl. Women’s Health)
Keywords
Where eli lilly benelux is headquartered
LocationHeadquarters
- HQ city
- Brussels
- HQ country
- Belgium
- HQ region
- Europe
Markets served
eli lilly benelux business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Operations, Supply Chain, Marketing or Sales, Personnel
Distribution channels1 record
Marketing channels3 records
eli lilly benelux product offering
Product offeringCore offering
Eli Lilly Benelux develops, markets, and distributes prescription pharmaceutical and biotechnology medicines across five core therapeutic domains: diabetes, oncology, immunology, pain, and neurodegeneration. The Belgian subsidiary operates clinical research programs and provides patient safety services, including adverse event reporting and anti-counterfeiting measures, while supporting healthcare professionals through the LillyPro portal. The company combines care and discovery to deliver medicines that improve quality of life for patients in Belgium.
Differentiator
Problem solved
Functional benefit
Products and services
- Diabetes Medicines Pharmaceutical medications for diabetes treatment, part of Lilly's therapeutic portfolio addressing diabetes disease management. Targeted at patients requiring diabetes treatment and the healthcare professionals who prescribe them in Belgium.
- Oncology Medicines Cancer treatment medications developed through Lilly's oncology research programs. Targeted at patients with cancer and the healthcare professionals (oncologists) who prescribe them in Belgium.
- Immunology Medicines Immunology-focused pharmaceutical products for immune system disorders. Targeted at patients with immunological conditions and the healthcare professionals who treat them in Belgium.
- Pain Medicines Pain management medications as part of Lilly's therapeutic offerings. Targeted at patients requiring pain management and the healthcare professionals who prescribe them in Belgium.
- Neurodegeneration Medicines Neurodegenerative disease treatments in Lilly's pharmaceutical portfolio. Targeted at patients with neurodegenerative conditions and the healthcare professionals who prescribe them in Belgium.
- Clinical Studies Clinical studies conducted by Lilly for drug development and scientific discovery. Targeted at researchers, healthcare professionals, and patients participating in Lilly's clinical research programs.
- Current Medicines Portfolio Lilly's current marketed medicines available for patients in Belgium, encompassing the full portfolio of prescription medicines across the company's therapeutic domains.
Companies that use eli lilly benelux
Customer profileSegments2 records
Ideal customer profiles2 records
eli lilly benelux technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
eli lilly benelux competitors and assessment
Company assessmentMarket position
Customer concentration
eli lilly benelux social profiles
Digital presenceeli lilly benelux financial estimates
Financial estimateRevenue estimate
Valuation estimate
eli lilly benelux leadership team
Management profileNumber of profiles
eli lilly benelux funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
eli lilly benelux M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about eli lilly benelux
What does eli lilly benelux do?
Eli Lilly Benelux develops, markets, and distributes prescription pharmaceutical and biotechnology medicines across five core therapeutic domains: diabetes, oncology, immunology, pain, and neurodegeneration. The Belgian subsidiary operates clinical research programs and provides patient safety services, including adverse event reporting and anti-counterfeiting measures, while supporting healthcare professionals through the LillyPro portal. The company combines care and discovery to deliver medicines that improve quality of life for patients in Belgium.
Is eli lilly benelux a public or private company?
eli lilly benelux is a public company. It is classified as public and is currently operating.
When was eli lilly benelux founded?
eli lilly benelux was founded in 1876.
Where is eli lilly benelux based?
eli lilly benelux is headquartered in Brussels, Belgium, in the Europe region.
Does eli lilly benelux have an API?
No public API is recorded for eli lilly benelux.
What industry is eli lilly benelux in?
eli lilly benelux's product category is Pharmaceuticals. Its primary akta.pro industry code is HLAIAAAA, Primary Care & General Medicine Pharmaceuticals, with a secondary code of HLAIAAAE, Cardiometabolic Pharmaceuticals (Cardiovascular/Diabetes/Obesity). Its NAICS code is 325412 and its SIC code is 2834.